IQVIA has not acquired Charles River Laboratories, as both entities operate as independent publicly traded corporations within the global healthcare and pharmaceutical services sectors. While major contract research organizations and clinical service providers frequently engage in strategic partnerships or industry consolidations, Charles River remains an independent enterprise listed on the New York Stock Exchange under its own corporate governance and management structure.